Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Closure

MA.27B, The Influence of Five Years of Adjuvant Anastrozole or Exemestane on Bone Mineral Density in Postmenopausal Women with Primary Breast Cancer - A Companion Study to MA.27, is officially closed to accrual as of May 30, 2008.
http://www.ctg.queensu.ca/trials/breast/ma27b/ma27b.html